Perforation of gastric metastasis during chemotherapy with ramucirumab

Research output: Contribution to journalArticlepeer-review

Abstract

A 59-year-old man received fifth line chemotherapy with ramucirumab and protein-bound paclitaxel for gastric metastasis from esophagogastric junction cancer. On day 3 of the third course, he had severe chest pain and a high fever. Esophagogastroduodenoscopy revealed gastric perforation at the point of the metastatic lesion.

Original languageEnglish
Article number100666
JournalCurrent Problems in Cancer
Volume45
Issue number2
DOIs
Publication statusPublished - Apr 2021

Keywords

  • Chemotherapy
  • Gastric metastasis
  • Gastrointestinal perforation
  • Ramucirumab

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'Perforation of gastric metastasis during chemotherapy with ramucirumab'. Together they form a unique fingerprint.

Cite this